Episode Details

Back to Episodes
Episode 388: ASCO GU 2025 - FGF3 Inhibition with LOXO-435 in Urothelial Cancer

Episode 388: ASCO GU 2025 - FGF3 Inhibition with LOXO-435 in Urothelial Cancer

Published 1 year, 8 months ago
Description

Gopa Iyer from MSKCC joins the show to discuss his initial results from this phase 2 trial.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us